LLY

742.34

+2.24%↑

UNH

524.47

+2.96%↑

JNJ

148.01

+0.7%↑

ABBV

172.39

+0.6%↑

NVO

80.97

+2.85%↑

LLY

742.34

+2.24%↑

UNH

524.47

+2.96%↑

JNJ

148.01

+0.7%↑

ABBV

172.39

+0.6%↑

NVO

80.97

+2.85%↑

LLY

742.34

+2.24%↑

UNH

524.47

+2.96%↑

JNJ

148.01

+0.7%↑

ABBV

172.39

+0.6%↑

NVO

80.97

+2.85%↑

LLY

742.34

+2.24%↑

UNH

524.47

+2.96%↑

JNJ

148.01

+0.7%↑

ABBV

172.39

+0.6%↑

NVO

80.97

+2.85%↑

LLY

742.34

+2.24%↑

UNH

524.47

+2.96%↑

JNJ

148.01

+0.7%↑

ABBV

172.39

+0.6%↑

NVO

80.97

+2.85%↑

Search

Beam Therapeutics Inc

Open

Sector Healthcare

24.39 4.14

Overview

Share price change

24h

Current

Min

23.3

Max

24.57

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+113.31 upside

Dividends

By Dow Jones

Next Earnings

25 Feb 2025

News Sentiment

By Acuity

69%

31%

350 / 392 Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

Beam Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

26 Sept 2024, 14:20 UTC

Acquisitions, Mergers, Takeovers

Pfizer Tanked A $5.4 Billion Takeover. Why Crispr, Agios, Beam Could Benefit. -- IBD

Peer Comparison

Price change

Beam Therapeutics Inc Forecast

Price Target

By TipRanks

113.31% upside

12 Months Forecast

Average 50 USD  113.31%

High 80 USD

Low 24 USD

Based on 15 Wall Street analysts offering 12 month price targets forBeam Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

15 ratings

10

Buy

5

Hold

0

Sell

Technical Score

By Trading Central

23.39 / 25.59Support & Resistance

Short Term

Bearish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

350 / 392 Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

$